Fig. 1From: Allogeneic mesenchymal stem cells as induction therapy are safe and feasible in renal allografts: pilot results of a multicenter randomized controlled trialStudy design and protocol for UC-MSCs administration in renal transplantation to prevent DGF and acute rejectionBack to article page